Stay updated with breaking news from Rezafungin Acetate. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Cidara Therapeutics, Inc. (NASDAQ:CDTX – Get Rating) was the target of a significant decrease in short interest during the month of May. As of May 15th, there was short interest totalling 2,220,000 shares, a decrease of 7.9% from the April 30th total of 2,410,000 shares. Based on an average trading volume of 3,070,000 shares, the […]
Cidara Therapeutics, Inc. (NASDAQ:CDTX – Get Rating) saw a large decrease in short interest in the month of April. As of April 15th, there was short interest totalling 3,080,000 shares, a decrease of 13.2% from the March 31st total of 3,550,000 shares. Based on an average trading volume of 3,590,000 shares, the short-interest ratio is […]
Should You Buy or Sell Cidara Therapeutics Stock? Get The Latest CDTX Stock Forecast, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat.
Should You Buy or Sell Cidara Therapeutics Stock? Get The Latest CDTX Stock Forecast, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat.
StockNews.com upgraded shares of Cidara Therapeutics (NASDAQ:CDTX – Get Rating) from a hold rating to a buy rating in a research note released on Friday morning. Several other analysts also recently issued reports on CDTX. Cantor Fitzgerald reissued an overweight rating and issued a $5.00 price target on shares of Cidara Therapeutics in a report […]